Scouting Report-Evernow: Improving Symptom Management & Treatment for Perimenopause & Menopause
The Driver: Evernow recently raised $28.5 million in a Series A funding led by NEA, with participation from 8VC, Refactor Capital and Coelius Capital, plus angel investors, among them Color CEO Othman Laraki, and Carla Harris. The San Francisco based company built its platform focusing on women’s health and more specifically those who suffer from adverse symptoms of perimenopause. The company claims its using its clinically-validated health intakes to fill gaps in care for me